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Abstract
Objective To investigate the psychosocial impact of
having an implantable cardioverter defibrillator (ICD) in
adults with Tetralogy of Fallot (ToF).
Methods Included were 26 ToF-patients with an ICD (age
44 ± 12 years), and two control groups consisting of 28
ToF-patients without an ICD (age 40 ± 10 years) and a
group of 35 ICD-patients of older age without ToF (age
72.0 ± 8 years). This last control group was chosen to
represent the ‘‘older general ICD population’’ with
acquired heart disease seen at the out-patient clinic.
Psychosocial functioning encompassed daily functioning,
subjective health status, quality of life, anxiety, depression,
coping and social support.
Results ToF-patients with ICD showed diminished psy-
chosocial functioning in comparison to ToF-patients
without ICD. This was reflected by diminished subjectively
perceived physical functioning (p = 0.01), general health
perception (p \ 0.01) and a lower satisfaction with life
(p = 0.02). In comparison to older ICD-patients, ToF-
patients with ICD showed less satisfaction with life
(p = 0.03), experienced more anxiety (p = 0.01) and
showed less favourable coping styles, although physical
functioning was better for ToF-patients with ICD than for
older ICD-patients (p = 0.01). More inappropriate shocks
were found in ToF-patients with ICD compared to the older
ICD-patients.
Conclusion In patients with ToF, ICD implantation had a
major impact on psychosocial functioning which should be
taken into account when considering ICD implantation in
these young patients. To help improve psychosocial func-
tioning, psychological counselling attuned to the specific
needs of these patients may be useful.
Keywords Congenital heart disease  ICD  Quality
of life  Tetralogy of Fallot  Inappropriate shocks
Introduction
The leading cause of mortality in adult patients with con-
genital heart disease (ConHD) is sudden cardiac death
(SCD) [1]. In comparison with the general population, an
adult patient with ConHD has a 25–100 fold increased risk
to die as a result of SCD [2]. Implantable cardioverter
defibrillators (ICDs) are being used as therapy for patients
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that are at high risk for developing, or have survived a life-
threatening cardiac arrhythmia [3]. However, the indication
of ICD therapy in patients with ConHD is still a matter of
debate. A recent publication from our group investigating
the efficacy of ICD therapy in ConHD patients demon-
strated that 23% of all patients received an appropriate
shock, and 41% of the investigated patients received at
least one inappropriate shock [4]. This inappropriate shock
rate is higher than in other patient groups. Other studies
reported an inappropriate shock rate of around 25%, and an
appropriate shock rate of around 22–30% in ConHD
patients [3].
Congenital heart disease patients not only have to cope
with an increased risk to die as a result of SCD [2]. In
addition, the implantation of an ICD with associated
inappropriate shocks, which occur when the patient is fully
conscious, may cause anxiety for shock, anxiety for pre-
mature death and stress, hereby worsening the psycholog-
ical problems [6, 7]. Patients receiving ICD therapy may
show reduced quality of life, subjective health status and
diminished social functioning. Anxiety and fear for ICD
discharge does not only affect the patient, it can also
influence the behaviour of relatives and friends surrounding
the patient. Sometimes these ‘‘significant others’’ experi-
ence fear and anxiety, which may have a cumulative anx-
iety arousing effect on the patient [8]. The aim of this study
was to investigate the psychosocial impact that ICD ther-
apy has in (young) adults with Tetralogy of Fallot (ToF).
We chose patients with ToF because most of the ICD
implantations in the ConHD population occur in these
patients [3].
Two control groups were selected; the first control group
consisted of ToF-patients without an ICD. We selected
these patients to investigate the impact of the ICD while
holding the groups comparable on cardiac diagnosis and
hemodynamic burden. The second control group consisted
of older acquired heart disease ICD patients. This group
represents the ‘‘general’’ ICD population as seen in an
outpatient clinic. By choosing this group, we could make a
comparison with a ‘‘general’’ average ICD patient. Age may
be a factor in acceptance of an ICD. Also, knowledge about
the psychosocial functioning of patients with an ICD comes
from studies focusing on these ‘‘regular ICD-patients’’.
These patients are older and have acquired heart disease.
The psychosocial problems seen in these older patients may
be quite different than those seen in younger ConHD
patients receiving ICD therapy. Young patients do not only
experience the problems associated with the ICD but also
carry the burden of having grown-up with a congenital heart
defect. They also experience more inappropriate shocks
than non-ConHD patients [4]. These shocks may lead to
anxiety, psychosocial problems and avoidance behaviour,
limiting patients in social contacts, and leisure time
activities. In addition, overprotective parents of ConHD
patients may be a limiting factor as well. Therefore, we
hypothesized that the psychosocial impact of receiving ICD
therapy in young ConHD patients may be more substantial.
Finally, we wanted to compare whether styles of coping
and adjustment to ICD therapy differed between younger
ConHD patients with an ICD (ToF ? ICD) and older
patients with acquired heart disease receiving ICD therapy
(ICD), when adjusted for the time-period of receiving ICD
therapy.
Methods
Study design and population
This is a cross-sectional, multicentre study.
Inclusion criteria
Our database consisted of three groups. The first group
consisted of Fallot-patients with ICD (ToF ? ICD). This
population was selected using the CONCOR [9] registry in
The Netherlands and a Belgian tertiary care centre adult
ConHD database. The CONCOR registry is a nationwide
database consisting of adult patients with ConHD, includ-
ing medical history. The selection of this patient sample is
described in detail in the paper of Yap et al. [4]. This group
was used as the study population. The second group con-
sisted of Fallot-patients without ICD (ToF) and was also
identified using the CONCOR registry. This ToF group
consisted of 28 patients without significant differences in
age, sex and NYHA class compared to the study group
ToF ? ICD. We used this group as our first control group.
The third group (ICD) consisted of 35 older ICD-patients
with another form of heart disease, mainly ischaemic heart
disease. These patients did not have ConHD. This group
was identified using the Erasmus MC ICD registry, and did
not show significant differences regarding gender com-
pared to the ToF ? ICD group. We used this last group as
our second control group. For all selected patients, data
were collected form medical records, with permission of
the patients and physicians.
This study was approved by the institutional ethical
committees. All patients provided informed consent before
participating in this study.
Patient sample
Of the 44 eligible patients from the ToF ? ICD group, 13
were lost to follow-up and 3 patients died before inclusion in
this study. The present patient sample consisted of the
remaining 28 adults of whom two refused to participate,
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resulting in a response rate of 93% for the ToF ? ICD group.
The mean age of this group was 44 years (±12 years).
There were no differences between participants and non-
participants on age, age at Fallot correction, shunt before
correction, reoperations, age at ICD implantation, follow-
up time, indication for ICD implantation, NYHA class or
the amount of shocks.
In order to ensure that ICDs of patients are programed
optimally, patients visited the outpatient clinic every
6 months, or sooner if they had complaints. The func-
tionality of the ICD device was assessed by skilled tech-
nicians and adapted if necessary. All appropriate and
inappropriate shocks were recorded.
Indications for ICD implantation in ToF-patients
The index event before ICD implantation was spontaneous
sustained ventricular tachycardia (VT) in 14 patients
(54%), cardiac arrest in 5 patients (19%), (pre) syncope in
5 patients (19%) and other in 2 patients (8%).
Assessment procedure
All patients were approached uniformly and signed an
informed consent before participating. All patients com-
pleted the questionnaires at home and returned them by
mail. Missing items were retrieved by means of a telephone
call.
Instruments
The psychological examination consisted of the following
questionnaires.
Biographical characteristics
A semi-structured questionnaire was designed to assess
biographical variables such as nationality, living condi-
tions, marital-, educational- and occupational status [10].
The educational attainments were evaluated excluding two
patients living in institutions because of psychosocial
problems.
Subjective health status
The subjective health status was assessed by the SF-36
Health Survey [11]. Good reliability and validity for the
Dutch version of the SF-36 has been reported [12].
Satisfaction with Life Scale
The Satisfaction with Life Scale (SWLS) was used as an
indicator of the satisfaction with life. This scale has been
proven psychometrically sound to be used in ConHD
patients [13].
Linear Analogue Scale Quality of Life
The Linear Analogue Scale (LAS) was used to measure self-
perceived quality of life. The LAS has been proven valid,
reliable and responsive for the ConHD population [13].
Hospital Anxiety and Depression Scale (HADS)
This scale measures the presence and severity of anxiety
and depression in patients. The HADS has been validated
for the general Dutch population and is stable across
medical settings and age groups [14, 15].
Utrecht Coping List
The Utrecht Coping List (UCL) is a reliable and stand-
ardised self-report questionnaire of coping styles. The
satisfactory validity of the UCL has been described else-
where [16]. Construct validity and predictive validity has
been examined for the UCL.
Implanted Devices Adjustment Scale
The Implanted Device Adjustment Scale (IDAS) measures
the psychological adjustment of a patient to an implanted
(ICD) pacemaker. The IDAS has been described valid,
reliable and responsive [17].
Perceived Social Support Scale
The Perceived Social Support Scale 12 item version
(PSSS12) measures the interactions and discrepancies that
people experience in receiving social support from their
direct environment [18].
Statistical methods
Biographical characteristics were analysed using Chi-
Square tests. Because of the skewed nature of the data,
Mann–Whitney U tests were used to test for differences
between the ToF ? ICD group versus both control groups
on all questionnaires. Comparison with normative data was
made using Students’ t tests, since raw data for the norm
groups were not available, and only mean and standard
deviations were available. Descriptive statistics of contin-
uous variables are expressed as medians with quartiles.
Stepwise multiple regression was used to correct for age at
implantation, and the higher age in the ICD group. The data
were analysed using the statistical package SPSS PSAW
17.0.2 ENG for Windows, Release 17.0.2 (Mar 11, 2009).
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Results
Population characteristics
Biographical characteristics
The main biographical and medical characteristics for the
three groups are outlined in Table 1. No differences in
gender were found between the three groups. Patients from
the ToF ? ICD group were living significantly less often
on their own compared to patients from the ICD group.
Patients in the ToF ? ICD group more often had no rela-
tionship and were less often widowed than the older ICD
patients. After adjusting for higher age at implantation in
the ICD group, it appeared that this variable did not have
an effect on the SF-36 results.
No significant differences were found between the three
groups with respect to occupational level or educational
attainment. In all three groups, the majority had an average
educational attainment.
Medical characteristics
No significant difference was found regarding age, the
amount of surgical procedures or re-operations between the
ToF ? ICD and the ToF group. As we selected older ICD
patients to represent the ‘‘normal’’ ICD population as our
second control group, the patients in the ToF ? ICD group
were younger than those in the ICD group. Also, patients in
the ToF ? ICD group were (as planned) significantly older
at the time of surgical Fallot correction than patients from
the ToF group. Both indication for ICD implantation
(primary and secondary) and follow-up time after ICD did
not differ between the two groups. The majority of patients
in the ICD group were NYHA class II resulting in a sig-
nificant difference with regard to the ToF ? ICD group
and the ToF group (majority NYHA class I). When com-
paring QRS duration, a significant difference was found
between all three groups. Group ToF ? ICD had the
highest QRS duration (176 ms) followed by the ToF group
(150 ms) and the ICD group (138 ms). No difference was
found between the ToF ? ICD and ToF groups when
comparing right ventricular dilatation. Right ventricular
function was significantly worse in the ToF ? ICD group
compared to the ToF group (p \ 0.01). Remarkably,
patients from the ToF ? ICD group less often had severe
pulmonary regurgitation compared to patients form the
ToF group. When analyzing the occurrence of appropriate
and inappropriate shocks, a significantly higher incidence
of inappropriate shocks was observed in the ToF ? ICD
group versus the ICD group (p = 0.03). Also, the abso-
lute number of inappropriate shocks was higher in the
ToF ? ICD group (p = 0.03) and also the amount of
appropriate shocks was higher in the ToF ? ICD group
(p = 0.03).
Scores on instruments (see Table 2)
Subjective health status (SF36)
On all SF-36 scales except for one, the median for the
ToF ? ICD group was lower, indicating more unfavour-
able outcomes, than for the ToF group. Two significant
group effects between the ToF ? ICD group versus the
ToF group were found: patients from the ToF ? ICD
group scored significantly lower on physical functioning
compared to the ToF group (p = 0.01) and also on general
health perceptions patients from the ToF ? ICD group
scored significantly lower than the ToF group (p \ 0.01).
When comparing the ToF ? ICD versus the ICD group,
one significant group effect was found. On physical func-
tioning the ToF ? ICD group obtained a higher, more
favourable mean score than the ICD group (p = 0.01).
No other significant differences were found between the
three groups.
Satisfaction with Life Scale
Patients of the ToF ? ICD group scored significantly
lower compared to patients from the ToF group (p = 0.02).
Also, a significantly lower score was found in the
ToF ? ICD group compared to the ICD group (p = 0.03).
Linear Analogue Scale Quality of Life
The ToF ? ICD group showed a trend towards a less
favourable result than the ToF group (p = 0.06).
Hospital Anxiety and Depression Scale
Patients from the ToF ? ICD group reported significantly
more anxiety than patients from the ICD group (p = 0.01).
No other significant differences were found on the anxiety
and depression scale between the three groups.
Utrecht Coping List
Patients from the ToF ? ICD group scored significantly
higher on Palliative reactions (i.e. seeking diversion in
unhealthy manners) compared to patients from the ICD
group (p \ 0.01). Also significantly higher scores were
found on seeking social support in the ToF ? ICD group
compared to the ICD group (p \ 0.0001). Patients from the
ToF ? ICD group also scored higher on expressions of
(negative) emotions compared to the ICD-patients group
(p = 0.01). No differences in scores were found between
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Table 1 Biographical and medical characteristics
ToF ? ICD (N = 26) ToF (N = 28) ICD (N = 35) Group effect
ToF ? ICD vs.
ToF (p value)
ToF ? ICD vs.
ICD (p value)
Response rate 93% 88%
Gender
Male 15 (57.7%) 19 (67.9%) 28 (80.0%) 0.4 0.06
Agea 44 (±11.58) 40 (±10.26) 72 (±8.28) 0.1 <0.0001
Nationality
Dutch 18 (69.2%) 28 (100.0%) 35 (100.0%) <0.01 <0.0001
Belgian 8 (30.8%) 0 (0.0%) 0 (0.0%) <0.01 0.001
Living conditions
With parents 2 (7.7%) 3 (10.7%) 0 (0.0%) 1.0 0.1
Living alone 21 (80.8%) 22 (78.6%) 34 (97.1%) 0.1 0.02
Institution/home replacement 3 (11.5%) 3 (10.7%) 1 (2.9%) 1.0 0.1
Marital status
No relationship 8 (30.8%) 8 (28.6%) 2 (5.7%) 0.9 0.02
Stable relationship 0 (0.0%) 2 (7.1%) 0 (0.0%) 0.5 –
Cohabitant 1 (3.8%) 6 (21.4%) 0 (0.0%) 0.1 0.2
Married 15 (57.7%) 9 (32.1%) 21 (60.0%) 0.06 0.9
Divorced 1 (3.8%) 0 (0.0%) 1 (2.9%) 0.5 0.8
Cohabitant or married after divorce 1 (3.8%) 1 (3.6%) 1 (2.9%) 1.0 0.8
Widowed 0 (0.0%) 2 (7.1%) 8 (22.9%) 0.5 0.02
Stable relationship or
married after being widowed
0 (0.0%) 0 (0.0%) 2 (5.7%) – 0.2
Occupational level
Elementary 0 (0.0%) 1 (3.6%) 0 (0.0%) 1.0 –
Lower 3 (11.5%) 6 (21.4%) 0 (0.0%) 1.0 0.5
Average 7 (26.9%) 8 (28.6%) 6 (17.1%) 0.3 0.3
Higher 3 (11.5%) 8 (28.6%) 1 (2.9%) 0.5 1.0
No job/missing data 13 (50.0%) 5 (17.9%) 28 (80.0%)
Educational attainmentb
Lower 2 (7.7%) 2 (7.1%) 8 (22.9%) 1.0 0.1
Average 17 (65.4%) 21 (75.0%) 20 (57.1%) 0.7 0.3
Higher 5 (19.2%) 5 (17.9%) 5 (14.3%) 1.0 0.5
Other 0 (0.0%) 0 (0.0%) 1 (2.9%)
Missing 1 (3.8%) 0 (0.0%) 0 (0.0%)
Medical data
Age fallot correction (years)a 9.9 (±10.80) 5.9 (±3.91) – 0.1 –
Shunt before correction 8 (30.8%) 13 (48.1%) – 0.2 –
Reoperations 15 (57.7%) 12 (44.4%) – 0.3 –
Age at implantation (years)a 36.5 (±11.25) – 64.7 (±8.19) – <0.0001
Follow-up (years)a 7.9 (±3.73) – 7.4 (±2.08) – 0.5
Indication for ICD
Primary prevention 6 (23.1%) – 13 (37.1%) – 0.2
Secondary prevention 20 (76.9%) – 22 (62.9%) – 0.2
NYHA-class
I 19 (73.1%) 24 (85.7%) 9 (25.7%) 0.2 <0.0001
II 5 (19.2%) 3 (10.7%) 24 (68.6%) 0.5 <0.0001
III 2 (7.7%) 1 (3.6%) 2 (5.7%) 0.6 1.0
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the ToF ? ICD and the ToF group. No other significant
differences were found on the other scales of the UCL.
Implanted Devices Adjustment Scale
No significant differences were found between the two ICD
groups on any of the IDAS domains.
Perceived Social Support Scale
No significant differences were found between the three
groups on any of the PSSS12 domains.
Primary versus secondary indication for ICD
implantation
In order to assess whether the indication for ICD implan-
tation had effect on the outcomes, we compared the scores
on different scales of patients with a primary indication
versus a secondary indication for ICD implantation.
In the ToF ? ICD group, no significant differences were
found between the two indication groups.
In the ICD group, no significant differences were found
between the two indication groups, except for the body
awareness scale of the IDAS. Here, patients with a sec-
ondary indication showed less favourable outcome.
When combining the ToF ? ICD group with the ICD
group, a less favourable outcome on the UCL scale in
palliative reactions was observed for patients with sec-
ondary indication for ICD.
Normative data
When comparing the ToF ? ICD group with normative
data, the following results were obtained.
Subjective health status (SF36)
Normative data for the Dutch population were obtained
from Aaronson et al. [12]. Patients from the ToF ? ICD
group obtained significantly lower results on physical
functioning, social functioning, role limitations due to
physical functioning, general mental health, vitality and
general health perceptions. No significant difference on the
Table 1 continued
ToF ? ICD (N = 26) ToF (N = 28) ICD (N = 35) Group effect
ToF ? ICD vs.
ToF (p value)
ToF ? ICD vs.
ICD (p value)
Brady pacingc 7 (33.3%) (0.0%) 15 (42.9%) 0.5
QRS durationa 176 (±27.2) 150 (±25.2) 138 (±39.3) <0.01 <0.0001
RV dilatation
None 2 (10.0%) 6 (21.4%) 0.195
Moderate 11 (55.0%) 18 (64.3%)
Severe 7 (35.0%) 4 (14.3%)
RV function
Good 10 (50.0%) 26 (92.9%) <0.01
Reduced 10 (50.0%) 2 (7.1%)
Pulmonary regurgitation
None/mild 12 (63.2%) 13 (46.4%) 0.05
Moderate 6 (31.6%) 5 (17.9%)
Severe 1 (5.3%) 10 (35.7%)
Inappropriate ICD shocks 10 (38.5%) 5 (14.3%) 0.03
Appropriate ICD shocks 2 (7.7%) 11 (31.4%) 0.03
ToF ? ICD, patients with Tetralogy of Fallot with an ICD
ToF, patients with Tetralogy of Fallot (without an ICD)
ICD, patients with ICD (without congenital heart disease)
NYHA New York Heart Association class
a Data are presented as mean (±SD)
b Excluding two patients living in institutions because of psychosocial problems
c There were 5 patients in the ToF ? ICD group of which the ECG could not be examined
The bold numbers in the text indicate significant results
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SF-36 scales bodily pain and role limitations due to emo-
tional functioning were found.
Satisfaction with Life Scale
Normative data were obtained from Moons et al. [13].
Patients from the ToF ? ICD group obtained significantly
less favourable outcomes compared to the general Belgium
population.
Linear Analogue Scale Quality of Life
Normative data were obtained from Moons et al. [13]. No
significant differences were found between the ToF ? ICD
group compared to the normative data.
Hospital Anxiety and Depression Scale
Normative data for the HADS have been obtained from
Spinhoven et al. [14]. When comparing the ToF ? ICD
group with normative data, no significant differences were
found.
Utrecht Coping List
Normative data for the Dutch population were obtained
from Schreurs et al. [16]. Patients from the ToF ? ICD
group obtained significantly less favourable outcomes on
palliative reactions and seeking social support.
Discussion
The main finding of this study is that ToF-patients with an
ICD show less favourable psychosocial functioning com-
pared to ToF-patients without ICD and to the older
acquired heart disease ICD-patients.
To our knowledge, this is the first psychosocial study
carried out in this specific group, Fallot-patients with ICD.
Data were compared with two control groups: Fallot-
patients without ICD and older ‘‘regular’’ ICD-patients
without ConHD. Clinically relevant areas of psychosocial
functioning together with medical correlates for psycho-
social outcomes were investigated, using standardized and
validated questionnaires.
Psychosocial functioning and ICD therapy
Despite a younger age (40 vs. 72 years) and lower NYHA
class (I vs. II), Fallot-patients with ICD scored less
favourable on instruments assessing subjective health sta-
tus, anxiety, satisfaction with life and coping (more neg-
ative emotions, more palliative reactions such as smokingT
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and drinking and less seeking of social support) compared
to older ICD-patients. After correction for the higher age in
the ICD group using stepwise multiple regression, all
conclusions drawn remained the same.
In contrast to the overall good quality of life reported
before [13], in our study we found that Fallot-patients with
ICD showed a less favourable quality of life outcome than
Fallot-patients without ICD. Our findings, together with the
findings from literature indicate that the ConHD back-
ground of these ICD-patients cannot be the sole reason for
the lower quality of life observed in this study. In fact, they
confirm our hypothesis that ICD therapy in young ConHD
patients is associated with worse psychosocial functioning.
Between the study of Yap et al. [4] and the start of our own
study, patients with less favourable medical outcome have
died in the ToF ? ICD group. This means that it might
even be possible that our present outcomes could have been
worse as we face a positive selection of patients.
Anxiety in Fallot-patients receiving ICD therapy
We found anxiety to be a problematic psychosocial reac-
tion for young Fallot-patients receiving ICD therapy. This
is in line with the review of Sears et al. 2009 [19]. Our
results on anxiety were statistically significant and in
addition clear trends were observed in the other data, also
pointing towards the same direction of a less favourable
psychological outcome for Fallot-patients with ICD com-
pared to both control groups. In addition, patients reported
a lower satisfaction with life.
In literature [20], a clinical cut-off value of 8 is con-
sidered clinically significant on the anxiety scale of the
HADS. Our ToF ? ICD group obtained a median score of
6 and did not show a significant difference on anxiety level
compared to normative data. This finding might be
explained by assuming that the HADS instrument may not
be sensitive enough to screen for disease-specific anxiety in
this unique ConHD population. We assume that using a
clinical interview, high levels of anxiety might have been
found, as in the article of Bromberg et al. [21].
Role of appropriate and inappropriate ICD shocks
The present data show that Fallot-patients receiving ICD
therapy have a higher rate of inappropriate ICD discharges
compared to ‘‘regular’’ ICD-patients. Despite optimal
programing, 39% of the Fallot-patients with ICD suffered
from one or more inappropriate ICD shocks. The inap-
propriate shock rate was higher than reported in previous
studies in non-ConHD patients [3, 5]. Since Fallot-patients
are known to have a high arrhythmia burden, the inap-
propriate shocks we found may be due to atrial arrhythmias
[4, 22–24].
Furthermore, ToF ICD-patients are in general younger
than the traditional ICD-patient group and tend to lead
more active lives, practising sports and other leisure
activities. These activities inducing sinus tachycardia may
result in inappropriate ICD therapy. Not only the inap-
propriate shock rate in ToF ? ICD patients was higher
than that in the older ICD group but also the number of
inappropriate shocks per patient was significantly higher.
As most inappropriate shocks occur when the patient is
fully conscious, this may have serious psychosocial con-
sequences and it may lead to serious anxiety and stress,
possibly resulting in avoidance behaviour. Our findings are
in line with Vasquez et al. [7], who showed that ICD
patients who had a history of more inappropriate shocks
with age below 50 and female gender were at higher
risk for developing psychosocial problems. Moreover,
avoidance behaviour has been reported for ICD patients,
which may be a limiting factor in social and sexual
activities, but also in practising sports. Out of fear for an
ICD discharge, 39% of the ICD-patients avoid physical
exertion [25], even though physical exercise is well known
to have a beneficial effect on health and can be effective in
preventing depression.
Although there is lack of evidence in mortality benefit,
the threshold for using ICD therapy in ConHD patients
seems to have lowered over time. The guidelines for ICD
implantation in this patient population are based on limited
data. With the high rate of inappropriate shocks, balancing
the benefit-risk ratio for ICD implantation remains difficult,
especially taking psychosocial problems into account.
Medical background
The differences in QRS duration as seen in Table 1 could
be explained by the ConHD background in combination
with pacemaker therapy differences between groups. ToF-
patients have a higher QRS duration as a result of right
ventricular dilatation, diminished function, or post-surgery
for their ConHD background. Some of the patients in the
ToF ? ICD group also received constant pacing therapy
next to the ICD therapy which may also have resulted into
a longer QRS duration. The long QRS duration seen in the
ToF ? ICD group can also be the result of selection, as a
QRS duration [180 ms is a predictor for SCD and may
have been used as a criterium for ICD implantation [26].
Despite the diminished RV function, patients in the
ToF ? ICD group were in good clinical condition with the
majority being in NYHA class I.
Clinical implications
When considering ICD therapy in young patients, the
psychosocial impact should be taken into account. The
Clin Res Cardiol (2012) 101:509–519 517
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findings in this study provide a solid argument for careful
assessment and counselling in patients with Tetralogy of
Fallot. The threshold for ICD implantation should be high,
especially in case of primary prevention. In patients
needing an ICD, routinely applied comprehensive and
multidisciplinary psychosocial aftercare is advised. We see
an opportunity for a shared decision-making model in this
situation. In this way, patients can become well informed
about all possible consequences of ICD therapy, and can
decide the best treatment option together with the clinician.
In order to facilitate acceptance of ICD therapy, we
recommend cognitive behavioural techniques such as
psycho-education, cognitive re-appraisal and relaxation
techniques to improve quality of life of these patients.
These techniques have been found to improve the quality
of life in the ‘‘general’’ older ICD population [7, 27, 28].
Limitations
The patients included in this study were all followed in a
tertiary (academic) medical centre. Therefore, this study
may not be representative for all Fallot-patients. In addi-
tion, although we tried to create comparable groups, some
differences were present. Furthermore, because of the
small sample size, often encountered in these patient
groups, several nearly significant trends were observed.
With a larger sample size these trends might have become
significant.
Although no significant differences were found between
the three groups, a trend was visible in which the older ICD
patients more often had male gender.
Unfortunately, data regarding psychosocial interven-
tions (so called ‘‘medical consumption’’ or ‘‘psychothera-
peutic counselling’’) are not systematically available.
Furthermore, as could be expected, a significant age
difference was found between the ToF ? ICD and the—by
definition—older ICD group, which resulted in a later age
at implantation in the ICD group. In addition, patients with
the Belgian nationality (N = 8) were only found in the
ToF ? ICD group. To which extent these inter-group dif-
ferences have influenced our results is unknown.
Despite the fact that patients in the ICD group were
more often in NYHA class II compared to the ToF and the
ToF ? ICD group, we remarkably found that our younger
NYHA class I ToF ? ICD patients obtained less favour-
able results than the other ICD group with worse NYHA
class. This noteworthy finding reflects the psychosocial
importance of our results in the ToF ? ICD group.
Future research
Future research should investigate the role of inappropriate
shocks on psychosocial outcome in a larger cohort, as the
current cohort was not large enough to perform further
subanalyses. In addition, the impact of ICD therapy in
young adults with ConHD on activities such as practising
sports, sexuality and driving a car [29] should be studied.
We recommend using a semi-structured clinical interview
to assess these points, as questionnaires may not be specific
enough.
Different programing strategies, such as the application
of antitachycardia pacing therapy and higher rate cut-offs
for arrhythmia detection, may prevent inappropriate ICD
therapy and may have a beneficial effect on psychosocial
functioning.
Recently, the subcutane ICD (sICD) has been introduced
for patients requiring ICD therapy [30, 31]. In this study,
sICD therapy appeared to have a very low rate of inappro-
priate shocks. This therefore may be a good alternative for
ConHD patients who require ICD therapy and suffer from a
lot of inappropriate shocks. The sICD is relatively easy to
implant, and because the leads are subcutaneous, replace-
ment and complication rates appear to be lower as well.
Future research could concentrate on the application and
psychosocial impact of having an sICD in ConHD patients.
Conclusion
Implantable cardioverter defibrillators implantation has a
major psychosocial impact in young adults with ToF. This
group shows clinically significant psychosocial problems
that have to be recognized and treated appropriately. The
information obtained from this study can be used to guide
adequate counselling and development of interventions
aimed at enhancing psychosocial functioning and improv-
ing quality of life. Our results provided information that is
not readily apparent from routine clinical investigations.
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